Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro

Platelets ◽  
2005 ◽  
Vol 16 (8) ◽  
pp. 469-473 ◽  
Author(s):  
Saulnier Pierre ◽  
Lynn Crosbie ◽  
Asim K. Duttaroy
2014 ◽  
Vol 21 (4) ◽  
pp. 286-290 ◽  
Author(s):  
Ling-geng Yan ◽  
Jun-shan Ruan ◽  
Lei Zhang ◽  
Fang-tian Fan ◽  
Feng Zhang ◽  
...  

1993 ◽  
Vol 70 (05) ◽  
pp. 834-837 ◽  
Author(s):  
Akira Suehiro ◽  
Yoshio Oura ◽  
Motoo Ueda ◽  
Eizo Kakishita

SummaryWe investigated the effect of staphylokinase (SAK), which has specific thrombolytic properties, on human platelet aggregation. Platelet aggregation induced with collagen was observed following preincubation of platelets in platelet-rich plasma (PRP) or washed platelet suspension (WP) with SAK at 37° C for 30 min. SAK inhibited platelet aggregation in PRP only at the highest examined concentration (1 x 10-4 g/ml). Although SAK did not inhibit platelet aggregation in WP which contained fibrinogen, it did when the platelets had been preincubated with SAK and plasminogen. The most effective concentration in WP was 1 x 10-6 g/ml. The effect could be inhibited by adding aprotinin or α2-antiplasmin. The highest generation of plasmin in the same preincubation fluid was detected at 1 x 10-6 g/ml SAK. We concluded that SAK can inhibit platelet aggregation in WP by generating plasmin and/or fibrinogen degradation products, but is only partially effective in PRP because of the existence of α2-antiplasmin.


1983 ◽  
Vol 49 (02) ◽  
pp. 081-083 ◽  
Author(s):  
Vittorio Bertelé ◽  
Maria Carla Roncaglioni ◽  
Maria Benedetta Donati ◽  
Giovanni de Gaetano

SummaryIt has recently been reported that heparin neutralizes the inhibitory effect of prostacyclin (PGI2) on human platelet aggregation. The mechanism of this interaction has not yet been unequivocally established. We present here evidence that heparin (Liquemin Roche) does not react directly with PGI2 but counteracts its inhibitory effect by potentiating platelet aggregation. In the absence of heparin, PGI2 was a less effective inhibitor of platelet aggregation induced by the combination of ADP and serotonin than by ADP alone. Moreover, the inhibitory effect of PGI2 was similarly reduced when increasing the concentrations of ADP (in the absence of heparin). The lack of a specific interaction between heparin and PGI2 is supported by the observation that, in the presence of heparin, other prostaglandins such as PGD2 and PGE1, and a non-prostanoid compound such as adenosine also appeared to lose their inhibitory potency. It is concluded that heparin opposes platelet aggregation inhibitory effect of PGI2 by enhancement of platelet aggregation.


2020 ◽  
Vol 75 (2) ◽  
pp. 215-222
Author(s):  
Marcelo Alarcón ◽  
Michelle Bustos ◽  
Diego Mendez ◽  
Eduardo Fuentes ◽  
Ivan Palomo ◽  
...  

Circulation ◽  
1998 ◽  
Vol 97 (15) ◽  
pp. 1481-1487 ◽  
Author(s):  
André Gries ◽  
Christoph Bode ◽  
Karlheinz Peter ◽  
Axel Herr ◽  
Hubert Böhrer ◽  
...  

1986 ◽  
Vol 42 (1) ◽  
pp. 113-114
Author(s):  
B. Gachályi ◽  
K. Tihanyi ◽  
Á. Vas ◽  
B. Nádas ◽  
A. Káldor

1988 ◽  
Vol 44 (10) ◽  
pp. 892-894 ◽  
Author(s):  
P. P. Gazzaniga ◽  
G. Di Macco ◽  
R. La Mancusa ◽  
A. Oddi ◽  
G. Pappalardo ◽  
...  

2006 ◽  
Vol 774 (1) ◽  
pp. 281-290 ◽  
Author(s):  
ROBERT L. JESSE ◽  
KATHY LOESSER ◽  
DAVID M. EICH ◽  
YONG ZHEN QIAN ◽  
MICHAEL L. HESS ◽  
...  

2014 ◽  
Vol 133 (2) ◽  
pp. 211-217 ◽  
Author(s):  
Ke Xiang ◽  
Gang Liu ◽  
Ya-Jun Zhou ◽  
Hong-Zhen Hao ◽  
Zhao Yin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document